[{"NetIncomeLoss_2_Q2_USD":-111122860.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2_Q2_pure":0.927,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":17.92,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":1168099.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-160742577.0,"Depreciation_2_Q2_USD":281102.0,"Depreciation_1_Q2_USD":132300.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":5595209.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":282573395.0,"PaymentsToAcquireInvestments_2_Q2_USD":284600154.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":22.4,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_Q2_shares":742509.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":4589818.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2_Q2_USD":5178979.0,"AssetsCurrent_0_Q2_USD":418573378.0,"OperatingLeaseExpense_2_Q2_USD":1600000.0,"OperatingLeaseExpense_1_Q2_USD":800000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":75541923.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":41445557.0,"CommonStockSharesIssued_0_Q2_shares":66777737.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":1791905.0,"StockIssuedDuringPeriodValueIssuedForServices_2_Q2_USD":107056.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q2_USD":53523.0,"Assets_0_Q2_USD":440930824.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":1313298.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":1039782.0,"ShareBasedCompensation_2_Q2_USD":12451431.0,"ShareBasedCompensation_1_Q2_USD":6947134.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":543137.0,"RestrictedCashCurrent_0_Q2_USD":1400000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":66429371.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":65767737.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":17.92,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":1039782.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":1313298.0,"AccountsReceivableNetCurrent_0_Q2_USD":2353255.0,"IncomeTaxExpenseBenefit_2_Q2_USD":3281.0,"CommonStockValue_0_Q2_USD":6678.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":143380.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":25000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":282047188.0,"AvailableForSaleSecuritiesCurrent_0_Q2_USD":278468502.0,"IncreaseDecreaseInInventories_2_Q2_USD":2335042.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q2_USD":19383111.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":20270675.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-110083078.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":11412697.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1952037.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0131,"OtherAssetsNoncurrent_0_Q2_USD":86084.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":129290445.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":21158241.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_2_Q2_USD":123879626.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1199576320.0,"Liabilities_0_Q2_USD":61400956.0,"OperatingLeaseLiability_0_Q2_USD":25100000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":277300000.0,"MoneyMarketFundsAtCarryingValue_0_Q2_USD":100900000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":18.71,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-62398960.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":276868209.0,"ProceedsFromIssuanceOfCommonStock_0_Q2_USD":5600000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":23053596.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":2353255.0,"CommonStockSharesOutstanding_0_Q2_shares":55507497.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":6112166.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q2_USD":47700000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3789533.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-111119579.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-63712258.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":12451431.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":6947134.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-98251015.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":0.0,"LiabilitiesCurrent_0_Q2_USD":40242715.0,"LeaseCost_2_Q2_USD":160341.0,"AccountsPayableCurrent_0_Q2_USD":5472987.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4726134.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2_Q2_pure":0.916,"ProceedsFromStockOptionsExercised_2_Q2_USD":5178979.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"IncreaseDecreaseInDeferredIncomeTaxes_2_Q2_USD":-264609.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":25000.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_2_Q2_USD":107055.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":526908.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2000687.0,"AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_2_Q2_USD":-5705186.0,"AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_1_Q2_USD":-5705186.0,"NetIncomeLoss_1_Q2_USD":-63712258.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":130690445.0,"ResearchAndDevelopmentExpense_1_Q2_USD":25204857.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-821221229.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6112166.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1587651.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":2990115.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":1906636.0,"ImpairmentOfLongLivedAssetsHeldForUse_2_Q2_USD":0.0,"OperatingIncomeLoss_2_Q2_USD":-113957841.0,"OperatingIncomeLoss_1_Q2_USD":-64872317.0,"InventoryNet_0_Q2_USD":2335042.0,"InvestmentIncomeInterest_2_Q2_USD":2838262.0,"InvestmentIncomeInterest_1_Q2_USD":1160059.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1194000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":23.85,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":3753550.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":12.14,"LiabilitiesAndStockholdersEquity_0_Q2_USD":440930824.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":5790220.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3973920.0,"OperatingExpenses_2_Q2_USD":116947956.0,"OperatingExpenses_1_Q2_USD":66778953.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":5184249.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":2821861.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.69,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.96,"ProfitLoss_2_Q2_USD":-111122860.0,"StockholdersEquity_0_Q2_USD":379529868.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":22049.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":334857.0,"OperatingLeaseCost_2_Q2_USD":219178.0,"ResearchAndDevelopmentExpense_2_Q2_USD":41208183.0,"Ticker":"ITCI","CIK":"1567514","name":"INTRA-CELLULAR THERAPIES, INC.","OfficialName":"Intra-Cellular Therapies Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"5718578003.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]